Kevin L Wingerd

Kevin L Wingerd, Ph.D.

  • Positions:
    Manager

    Manufacturing Development

    Process Development

    Emergent BioSolutions (Rockville, MD)

    Post Doctoral Fellow

    Center for the Study of Macular Degeneration

    University of California, Santa Barbara (Santa Barbara, CA)

  •  
  • Degrees:
     
    Ph.D., Molecular, Cellular and Developmental Biology, University of California, Santa Barbara (Santa Barbara, CA)
     
    B.A., Biology Pre-Med, Trinity International University (Deerfield, IL)
  •  
  • Past Advisors:
     
    Dennis O Clegg (as Post Doctoral Fellow)
     
    Dennis O Clegg (as Graduate Student - Ph.D.)
     
    Richard Thompson (as Research Associate)
  •  
  • Research:
    Scale-Up, Technology Transfer, At-Scale Process Characterization, and Process Validation at a commercial vaccine manufacturing site.

    Manufacturing development at Emergent Biosolutions Operations, Lansing is a far development group that transitions early phase one processes into the pilot plant or late Phase three processes into commercial manufacturing. I am the manager of the group of scientist and engineers, who scale, characterize and validate the manufacturing process. We work closely with quality control and the manufacturing assay development group for in-process and final product testing.

  •  
  • Other Experience:

    2007-present Vaccine Formulation with Aluminum and Non-Aluminum Adjuvants

    2006-present Operations Management for Biodefense Pilot Plant

    2005-present Fermentation Scale-up and Process Development, Bacillus sp., E. coli

    2005-present Protein Purification Scale-up and Process Development, Recombinant Vaccine Candidates

    2005-2008 Anthrax Vaccine Adsorbed Scale-Up and Technology Tranfer to New Manufacturing Building

Life Sciences
Communities:

Kevin Wingerd's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.


Kevin Wingerd's Publications (8)



One Figure

One Figure for Kevin L Wingerd

Tissue sections of superior cervical ganglia take from post-natal day 6 rats injected intrathorasically with antibodies to the alpha4 integrin or VCAM-1.


Websites


Join Epernicus (membership is free)
Epernicus is open to current and former research scientists.
First name:
Last name:
Email:

(we don't share your email)

Already a member?
Sign in to view Kevin's full profile.